These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22802261)

  • 1. The p38 MAPK-MK2 axis regulates E2F1 and FOXM1 expression after epirubicin treatment.
    de Olano N; Koo CY; Monteiro LJ; Pinto PH; Gomes AR; Aligue R; Lam EW
    Mol Cancer Res; 2012 Sep; 10(9):1189-202. PubMed ID: 22802261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J; de Olano N; Horimoto Y; Monteiro LJ; Langer JK; Aligue R; Hajji N; Lam EW
    Mol Cancer Ther; 2011 Jun; 10(6):1046-58. PubMed ID: 21518729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine regulation by MAPK activated kinase 2 in keratinocytes exposed to sulfur mustard.
    Yego EC; Dillman JF
    Toxicol In Vitro; 2013 Oct; 27(7):2067-75. PubMed ID: 23851002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 MAP kinase and MAPKAP kinases MK2/3 cooperatively phosphorylate epithelial keratins.
    Menon MB; Schwermann J; Singh AK; Franz-Wachtel M; Pabst O; Seidler U; Omary MB; Kotlyarov A; Gaestel M
    J Biol Chem; 2010 Oct; 285(43):33242-33251. PubMed ID: 20724476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of FOXO3a on Ser-7 by p38 promotes its nuclear localization in response to doxorubicin.
    Ho KK; McGuire VA; Koo CY; Muir KW; de Olano N; Maifoshie E; Kelly DJ; McGovern UB; Monteiro LJ; Gomes AR; Nebreda AR; Campbell DG; Arthur JS; Lam EW
    J Biol Chem; 2012 Jan; 287(2):1545-55. PubMed ID: 22128155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β-induced and p38
    Kulawik A; Engesser R; Ehlting C; Raue A; Albrecht U; Hahn B; Lehmann WD; Gaestel M; Klingmüller U; Häussinger D; Timmer J; Bode JG
    J Biol Chem; 2017 Apr; 292(15):6291-6302. PubMed ID: 28223354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
    Karunarathna U; Kongsema M; Zona S; Gong C; Cabrera E; Gomes AR; Man EP; Khongkow P; Tsang JW; Khoo US; Medema RH; Freire R; Lam EW
    Oncogene; 2016 Mar; 35(11):1433-44. PubMed ID: 26148240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXM1 targets NBS1 to regulate DNA damage-induced senescence and epirubicin resistance.
    Khongkow P; Karunarathna U; Khongkow M; Gong C; Gomes AR; Yagüe E; Monteiro LJ; Kongsema M; Zona S; Man EP; Tsang JW; Coombes RC; Wu KJ; Khoo US; Medema RH; Freire R; Lam EW
    Oncogene; 2014 Aug; 33(32):4144-55. PubMed ID: 24141789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.
    Dulos J; Wijnands FP; van den Hurk-van Alebeek JA; van Vugt MJ; Rullmann JA; Schot JJ; de Groot MW; Wagenaars JL; van Ravestein-van Os R; Smets RL; Vink PM; Hofstra CL; Nelissen RL; van Eenennaam H
    Clin Exp Rheumatol; 2013; 31(4):515-25. PubMed ID: 23558031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
    Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
    Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment.
    Monteiro LJ; Khongkow P; Kongsema M; Morris JR; Man C; Weekes D; Koo CY; Gomes AR; Pinto PH; Varghese V; Kenny LM; Charles Coombes R; Freire R; Medema RH; Lam EW
    Oncogene; 2013 Sep; 32(39):4634-45. PubMed ID: 23108394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.
    Gorog DA; Jabr RI; Tanno M; Sarafraz N; Clark JE; Fisher SG; Cao XB; Bellahcene M; Dighe K; Kabir AM; Quinlan RA; Kato K; Gaestel M; Marber MS; Heads RJ
    Cell Stress Chaperones; 2009 Sep; 14(5):477-89. PubMed ID: 19214782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras-MKK3-p38 to regulate in vitro cellular invasion.
    Behren A; Mühlen S; Acuna Sanhueza GA; Schwager C; Plinkert PK; Huber PE; Abdollahi A; Simon C
    Oncogene; 2010 Mar; 29(10):1519-30. PubMed ID: 20023695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a membrane Ig-induced p38 mitogen-activated protein kinase module that regulates cAMP response element binding protein phosphorylation and transcriptional activation in CH31 B cell lymphomas.
    Swart JM; Bergeron DM; Chiles TC
    J Immunol; 2000 Mar; 164(5):2311-9. PubMed ID: 10679065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of Argonaute 2 at serine-387 facilitates its localization to processing bodies.
    Zeng Y; Sankala H; Zhang X; Graves PR
    Biochem J; 2008 Aug; 413(3):429-36. PubMed ID: 18476811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
    Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
    Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAPKAPK-2-mediated LIM-kinase activation is critical for VEGF-induced actin remodeling and cell migration.
    Kobayashi M; Nishita M; Mishima T; Ohashi K; Mizuno K
    EMBO J; 2006 Feb; 25(4):713-26. PubMed ID: 16456544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression.
    Petrovic V; Costa RH; Lau LF; Raychaudhuri P; Tyner AL
    J Biol Chem; 2008 Jan; 283(1):453-460. PubMed ID: 17984092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism.
    Muniyappa H; Das KC
    Cell Signal; 2008 Apr; 20(4):675-83. PubMed ID: 18222647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.